Marc Brand, MD
Colon & Rectal Surgery · Lisle, ILNPI 1184799967
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Applied Medical Resources Corporation at 49.8% of the total. Reporting peaked in 2020 at $3,922 and has fallen 99.5% since, to $19 in 2025.
Across 18 payments — averaging $261.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$2K
- Baxter Healthcare$890
- Stryker$827
- AbbVie$131
- Olympus America Inc.$125
- Covidien LP$109
- plus $284 from 6 others
What the payments were for
- Consulting fees$89019%
- Travel & lodging$2,71858%
- Food & beverage$1,10223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 3 | $2,343 |
| Baxter Healthcare | 1 | $890 |
| Stryker | 2 | $827 |
| AbbVie | 2 | $131 |
| Olympus America Inc. | 1 | $125 |
| Covidien LP | 1 | $109 |
| Intuitive Surgical | 1 | $102 |
| Johnson & Johnson | 3 | $88 |
| Innovation Technologies Inc | 1 | $29 |
| Change Healthcare Technologies, LLC | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Teleflex LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GELPOINT PATH$2,329
- VOYANT$2,329
- STAPLER$2,329
- FLOSEAL$890
- 1688 HD 3 CHIP CAMERA$688
- 1588 HD 3 CHIP CAMERA$139
- 4-K$125
- EVIS EXERA$125
- STRATTICE$110
- Da Vinci Surgical System$102
How this compares
$4,709 in reported general payments places this provider in the 55th percentile of 79 colon & rectal surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $139 |
| Neomycin Sulfate | 14 | $62 |
| Metronidazole | 18 | $48 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Lisle
- Marc SingerChicago$201K
- Francisco QuinterosChicago$119K
- Lawrence PrabhakerRockford$81K
- Konstantin UmanskiyChicago$30K
- Vitaliy PoylinChicago$26K
- Monika KrezalekHighland Park$23K
- Jeremy SugrueNaperville$22K
- Neil HymanChicago$20K
- Amy HalversonChicago$19K
- Gerald GanttChicago$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.